Profound Debt To Assets from 2010 to 2026

PROF Stock  USD 5.83  -0.02  -0.34%   
Analyzing Profound Medical's Debt To Assets over time reveals patterns in financial health and operational efficiency. This reference data reflects Profound Medical's reported Debt To Assets across available disclosure periods. Debt To Assets are evolving in a expanding direction across reporting periods. Estimates suggest moderation to 0.03 this year. The regression slope computed for Profound Medical Debt To Assets from 2010 to 2026 measured a significance of 0.000029 , with r-value of -0.84 . All Financial Statement Accounts
 
Debt To Assets  
 First Reported
2010-12-31
 Previous Quarter
0.0334488
 Current Value
0.0318
 Quarterly Volatility
0.82170371
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
The Debt To Assets trend for Profound Medical Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Profound Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Profound Medical's Debt To Assets Growth Pattern

Below is the plot of the Debt To Assets of Profound Medical Corp over the last few years. It is Profound Medical's Debt To Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
Debt To Assets10 Years Trend
Slightly volatile
   Debt To Assets   
       Timeline  

Profound Debt To Assets Regression Statistics

Arithmetic Mean 0.66
Geometric Mean 0.23
Coefficient Of Variation 123.75
Mean Deviation 0.72
Median 0.26
Standard Deviation 0.82
Sample Variance 0.68
Range1.8738
R-Value-0.84
Mean Square Error 0.22
R-Squared 0.70
Significance 0.000029
Slope-0.14
Total Sum of Squares 10.80

Profound Debt To Assets History

2026 0.0318
2025 0.0334
2024 0.0729
2022 0.13
2021 0.0159
2020 0.016
2019 0.36

Methodology, Assumptions & Data Sources

Reference-level detail on Debt To Assets allows deeper analysis of Profound Medical's operating trajectory. Comparing this metric against sector peers can reveal relative positioning.

This section for Profound Medical Corp is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Sell-side coverage, where present, supplements the data shown. Values may update on different source schedules. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 6th, 2026